VAM
Visium Asset Management Portfolio holdings
AUM
$955M
This Quarter Return
-5.14%
1 Year Return
-4.5%
3 Year Return
+94.87%
5 Year Return
–
10 Year Return
–
AUM
$5.59B
AUM Growth
+$5.59B
(-11%)
Cap. Flow
-$16.4M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
24.12%
Holding
707
New
152
Increased
127
Reduced
136
Closed
235
Top Buys
| 1 |
Centene
CNC
|
$104M |
| 2 |
Biogen
BIIB
|
$99.3M |
| 3 |
Gilead Sciences
GILD
|
$68.8M |
| 4 |
Humana
HUM
|
$44.1M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$43.4M |
Top Sells
| 1 |
Perrigo
PRGO
|
$57.7M |
| 2 |
Brookdale Senior Living
BKD
|
$57.1M |
| 3 |
Labcorp
LH
|
$43.3M |
| 4 |
Zimmer Biomet
ZBH
|
$41.4M |
| 5 |
NextEra Energy, Inc.
NEE
|
$37.8M |
Sector Composition
| 1 | Healthcare | 53.73% |
| 2 | Financials | 7.63% |
| 3 | Energy | 6.37% |
| 4 | Consumer Discretionary | 5.8% |
| 5 | Technology | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Labcorp
LH
$23.1B
| $280M | 4.77% | 2,393,525 -370,011 | -13% | -$43.3M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $264M | 4.49% | 984,910 -110,775 | -10% | -$29.7M |
|
|
ENDP
3
DELISTED
Endo International plc
ENDP
| $188M | 3.2% | 6,680,749 +1,508,151 | +29% | +$42.5M |
|
4
Pacira BioSciences
PCRX
$1.2B
| $119M | 2.02% | 2,239,098 -51,912 | -2% | -$2.75M |
|
|
5
Centene
CNC
$14.3B
| $104M | 1.76% | +1,683,727 | New | +$104M |
|
|
6
Biogen
BIIB
$19.4B
| $99.3M | 1.69% | +381,642 | New | +$99.3M |
|
|
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $78M | 1.33% | 2,871,762 +422,895 | +17% | +$11.5M |
|
8
Neurocrine Biosciences
NBIX
$13.8B
| $73.7M | 1.25% | 1,864,222 -337,628 | -15% | -$13.4M |
|
9
Cigna
CI
$80.3B
| $71.2M | 1.21% | 518,635 +271,053 | +109% | +$37.2M |
|
10
Healthcare Realty
HR
$6.11B
| $70.1M | 1.19% | 2,382,215 -695,639 | -23% | -$20.5M |
|
|
11
Gilead Sciences
GILD
$140B
| $69.1M | 1.18% | 752,693 +749,179 | +21,320% | +$68.8M |
|
12
CONMED
CNMD
$1.68B
| $64.5M | 1.1% | 1,537,247 -269,768 | -15% | -$11.3M |
|
13
Pfizer
PFE
$141B
| $63.6M | 1.08% | 2,146,412 +486,897 | +29% | +$14.4M |
|
14
Align Technology
ALGN
$10.3B
| $58.4M | 0.99% | 803,625 +42,764 | +6% | +$3.11M |
|
15
McKesson
MCK
$85.4B
| $58.4M | 0.99% | 371,173 +174,669 | +89% | +$27.5M |
|
|
CBPO
16
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $55.5M | 0.94% | 484,619 +62,016 | +15% | +$7.1M |
|
|
17
Humana
HUM
$36.5B
| $55.1M | 0.94% | 301,193 +240,995 | +400% | +$44.1M |
|
|
SPNC
18
DELISTED
Spectranetics Corp
SPNC
| $52.2M | 0.89% | 3,592,940 +1,264,967 | +54% | +$18.4M |
|
|
19
Zimmer Biomet
ZBH
$21B
| $51.9M | 0.88% | 486,684 -388,384 | -44% | -$41.4M |
|
20
FibroGen
FGEN
$47.8M
| $50.3M | 0.86% | 2,363,759 +331,823 | +16% | +$7.06M |
|
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $50M | 0.85% | 1,559,922 +484,613 | +45% | +$15.5M |
|
|
22
Alnylam Pharmaceuticals
ALNY
$58.5B
| $49.7M | 0.85% | 792,295 +690,948 | +682% | +$43.4M |
|
|
SIOX
23
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $48.1M | 0.82% | 4,192,769 -884,616 | -17% | -$10.2M |
|
|
YHOO
24
DELISTED
Yahoo Inc
YHOO
| $48.1M | 0.82% | 1,305,704 -128,724 | -9% | -$4.74M |
|
|
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $46.5M | 0.79% | 2,804,261 -156,672 | -5% | -$2.6M |
|